A subscription to JoVE is required to view this content. Sign in or start your free trial.

Research Article

Knowledge Mapping of Traditional Chinese Medicine in Gastric Cancer Research: A Bibliometric Study from 2006 to 2025

151 views

⸱

DOI:

10.3791/71565

⸱

July 31st, 2026

 , 

In This Article

Summary

This study employs bibliometric analysis to map the current research landscape of traditional Chinese medicine in gastric cancer treatment and to further reveal the evolution of research hotspots.

Abstract

The study conducted a bibliometric analysis of 704 articles on traditional Chinese medicine for gastric cancer published between 2006 and 2025, using the Web of Science Core Collection WOSCC (literature database). Network analysis and visualization were performed using CiteSpace (bibliometric analysis software), VOSviewer (bibliometric mapping software), and Scimago Graphica (a free scientific data visualization application). From the perspectives of publication trends, collaborative networks, research themes, and the knowledge base, the study elucidates the current research landscape, core research forces, and the evolution of frontiers in this field. Over the past two decades, the number of publications continued to grow, reaching a historic peak of 102 in 2025. Articles published in the last decade account for over 75% of the total, indicating that this field is in an active research phase. China ranks first in publication volume (671 articles), total citations (13,447), and international collaboration centrality. Nanjing University of Chinese Medicine and Beijing University of Chinese Medicine are the core research institutions. Major publication outlets include the Journal of Ethnopharmacology and Frontiers in Pharmacology. Keyword cluster analysis identified nine major research themes: Helicobacter pylori, acupuncture, Chinese herbal injections, network pharmacology, molecular docking, metabolomics, and others. Research hotspots evolved from basic mechanistic exploration to comprehensive treatment strategies, and further to systematic studies supported by emerging technologies. Molecular docking and epithelial-mesenchymal transition represent the current research frontiers.

Introduction

Gastric cancer is one of the most common malignant tumors of the digestive tract worldwide, with its incidence and mortality rates consistently ranking among the leading malignancies, posing a serious threat to human health1. The disease often presents with insidious early symptoms, and most patients are already at an advanced stage at the time of initial diagnosis, missing the optimal window for curative surgery. Even with surgery, radiotherapy, and chemotherapy, the efficacy of conventional treatment modalities remains limited, and these approaches are frequently accompanied by severe adverse reactions that not only compromise patients' quality of life but often lead to treatment discontinuation2,3,4. Traditional Chinese medicine, as an important component of comprehensive cancer therapy, has demonstrated unique value in the prevention and treatment of gastric cancer5. In recent years, the treatment model combining traditional Chinese medicine with surgery, radiotherapy, and chemotherapy has become increasingly widespread. Multiple clinical studies have confirmed that traditional Chinese medicine can effectively alleviate chemotherapy-induced adverse reactions, inhibit tumor recurrence and metastasis, and improve patients' quality of life, while also exhibiting characteristics such as multi-pathway, multi-target effects and mild action6,7,8,9,10. In China, traditional Chinese medicine permeates the entire course of gastric cancer prevention and treatment, from early intervention in precancerous lesions to palliative care in advanced stages, having become an indispensable therapeutic approach11. However, with the rapid growth in related studies, this field faces challenges such as fragmented research topics, heterogeneous evidence quality, and unclear core research questions, underscoring the urgent need for a systematic review of the current research landscape.

Bibliometrics is an interdisciplinary field that treats the literature system as its research object and employs mathematical and statistical methods to quantitatively analyze the distributional characteristics and evolutionary patterns of knowledge carriers12. Compared with traditional review methods such as systematic reviews and meta-analyses, bibliometrics focuses more on revealing patterns and frontiers at the macro and meso levels. It can compensate for potential subjective selection bias in traditional reviews and is particularly well suited to the systematic sorting of large-scale, multidimensional characteristics of the literature. Based on this, the method can provide scholars with data to grasp the discipline's development trajectory, identify core research forces, and plan future research directions13,14,15. In recent years, this method has been widely applied in knowledge mapping and frontier analysis across various fields, offering a scientific basis for systematically tracing the development of disciplines. This study, based on the literature database, employs bibliometric analysis tools, including bibliometric mapping software and a free scientific data visualization application, to visually analyze the literature on traditional Chinese medicine for the treatment of gastric cancer from 2006 to 2025. By examining multiple dimensions such as publication trends, country distribution, institutional collaboration, author networks, journal distribution, keyword clustering, and co-cited references, this study systematically elucidates the current research status, core research forces, hot topics, and frontier evolution in this field, aiming to provide a reference for clinical practice and scientific research on the prevention and treatment of gastric cancer with traditional Chinese medicine.

Access restricted. Please log in or start a trial to view this content.

Protocol

Data Acquisition and Search Strategy

A topic search was conducted in the literature database using Boolean logical operators. The search strategy was designed using Medical Subject Headings (MeSH)- related concepts and free-text keywords adapted for the WOSCC database: "Stomach Neoplasms" for gastric cancer and "Medicine, Chinese Traditional" for traditional Chinese medicine, along with relevant entry terms. The search was limited to the "Topic" field. To comprehensively capture the broad literature on traditional Chinese medicine in gastric cancer research, two core research directions were prioritized, namely acupuncture and Chinese herbal medicine, as the primary retrieval axes, as these two modalities represented the most widely applied therapeutic approaches and had generated the largest body of published research in this field. The search strategy was constructed as follows: TS=(“traditional Chinese medicine*” OR “TCM” OR “Chinese herbal” OR “acupuncture” OR “herb medicine*”) AND TS=(“stomach neoplasm*” OR “gastric cancer*” OR “gastric tumor*” OR “gastric carcinoma*”). Core and extended keywords in the fields of gastric cancer and traditional Chinese medicine were selected hierarchically and combined within each group using the “OR” operator and between groups using the “AND” operator to ensure comprehensive coverage of relevant research topics. Wildcards were employed to avoid omission of related terms. The search period was limited from January 1, 2006, to December 31, 2025 (Table 1). The search was performed on March 18, 2026. The index categories included SCI-EXPANDED and SSCI.

Literature Screening Process and Criteria

The literature screening process was as follows: (1) Language filtering: only English articles were included. (2) Document type filtering: only journal articles (Article) and reviews (Review) were included; conference abstracts, editorials, letters, news items, etc., were excluded. All records retrieved from WOSCC were exported in their entirety without any manual preselection, ensuring an unbiased and reproducible screening process. When exporting records from the literature database, the export settings were as follows: record content was set to “Full Record and Cited References”; file format was set to ”Plain Text”; encoding was set to “UTF-8”; the file was named “20260318_TCM_gastric”. If disagreements arose during the screening process, they were resolved through consensus discussion between the two authors to ensure the accuracy of the screening results.

Data Import and Cleaning

After exporting the data, the first step was to convert the format and import it. The TXT files exported from WOSCC were uniformly stored in the “input” folder. Subsequently, using the bibliometric analysis tool's built-in data format conversion tool, the original literature records were converted into a format recognizable by bibliometric analysis tools; the converted files were stored in the “output” folder, and corresponding “data” and “project” folders were automatically generated, laying a structured data foundation for subsequent co-occurrence analysis, co-citation analysis, and keyword evolution analysis.

In the data cleaning step, to avoid interference from duplicate literature in the analysis results, the bibliometric analysis tools' data deduplication function for automated screening was used. This function identified and removed duplicate records using unique literature identifiers, ensuring that only one record was retained per publication. Specifically, in the data preprocessing interface of bibliometric analysis tools, the “Remove Duplicates” option was selected, and the system automatically scanned the dataset, removed redundant entries, and generated a deduplication log for verification. After cleaning, the remaining unique literature records were all included in subsequent analyses, thereby ensuring the accuracy of network construction and statistical counts. In addition, the TXT files exported from WOSCC were directly imported into a bibliometric mapping software and processed using the map-based bibliographic data function to construct collaboration and co-occurrence networks.

Analytical Tools

A bibliometric analysis tool was used to construct co-citation networks and analyze keyword evolution; bibliometric mapping software was used to construct and visualize collaborative and co-occurrence networks; a free scientific data-visualization application was used to visualize country/regional collaboration networks; and WPS Excel 2023( WPS spreadsheet) and GraphPad Prism 10.1 (scientific data analysis and graphing software) were used for basic statistical analysis and figure preparation.

Bibliometric Parameter Settings (bibliometric analysis tools)

In the bibliometric analysis, time slicing was set from 2006 to 2025 in 1-year intervals, and node selection was performed using the g-index (k = 5). Network simplification was conducted using the Pathfinder pruning algorithm, applied once to each time-slice network and once again after network merging. In the visualizations, node size was scaled proportionally to occurrence frequency, and link thickness reflected the strength of co-occurrence relationships16. Keywords extracted from the exported records were merged and standardized, based on which a co-occurrence matrix was generated. Subsequently, cluster analysis, timeline visualization, and burst detection were performed to identify thematic evolution and emerging research fronts. The analysis output included co-occurrence network files, cluster reports, and burst term lists for further visualization and interpretation.

Collaborative and Co-occurrence Network Analysis Workflow (bibliometric mapping software)

In the bibliometric mapping software analysis, thresholds were set based on the distribution of publication counts for each entity: a minimum of 4 publications for authors, 6 for institutions, 2 for countries, and 3 for journals. Under these thresholds, co-authorship networks for authors, institutions, countries, and journals, as well as a keyword co-occurrence network, were constructed separately. The network layout was optimized using the Linlog/modularity-based algorithm, and node sizes were weighted by publication counts or total citation counts, depending on the analysis objective17. The analysis generated node/edge statistics files, two-dimensional network maps, and density views for each network, which were used to interpret collaboration patterns and hotspot distributions.

Visualization of Country Collaboration Networks (a free scientific data visualization application)

A free scientific data-visualization application was used primarily to analyze and visualize country collaboration networks. The workflow involved importing GML-format country collaboration data exported from bibliometric mapping software into a free scientific data-visualization application, with the following parameters: (1) Node labels set to “Country”. (2) Node clustering based on the country name string. In the resulting country collaboration network, node diameter reflected the number of publications per country, and link thickness reflected the frequency of collaboration between countries18,19.

Basic Statistical Analysis and Visualization (WPS spreadsheet and a scientific data analysis and graphing software)

WPS spreadsheet and scientific data analysis and graphing software were used to perform descriptive statistical analyses and to convert analytical data into visual representations, including pie, bar, and column charts.

Access restricted. Please log in or start a trial to view this content.

Results

Annual Publication Output

An initial search yielded 724 records, which were refined to include only English-language articles and review articles, resulting in 704 publications: 548 articles and 156 review articles. From 2006 to 2025, the annual number of publications in traditional Chinese medicine for gastric cancer showed a fluctuating upward trend, reflecting a steady increase in research interest. The temporal evolution of research output can be categorized into three dis...

Access restricted. Please log in or start a trial to view this content.

Discussion

This study employs bibliometric methods to systematically delineate the research landscape of traditional Chinese medicine in the treatment of gastric cancer over the past two decades. This analysis not only outlines the global research landscape but also identifies key contributors, emerging themes, and potential future research directions in this field.

Macro-Level Development Trends and Research Power Distribution

Over the past two decades, resea...

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no conflicts of interest.

Acknowledgements

This work was supported by the Elite Research Fund of the Beijing Micro Love Charity Foundation under Grant No. JYKY2024-0100319019.

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
CiteSpaceChaomei Chen, Drexel University6.4.R1 (https://citespace.podia.com/)Used for constructing co-citation networks and analyzing keyword evolution.
VOSviewerCentre for Science and Technology Studies (CWTS), Leiden University1.6.19 (https://www.vosviewer.com/)Used for constructing and visualizing collaborative and co-occurrence networks.
Scimago GraphicaSCImago Lab1.0.25 (https://graphica.scimagojr.com/)Used for visualizing country/regional collaboration networks.
GraphPad PrismGraphPad Software10.1 (https://www.graphpad.com/)Used for basic statistical analysis and figure preparation.
WPS ExcelKingsoft Corporation2023 (https://www.wps.com/)Used for descriptive statistical analysis and data management.
Web of Science Core CollectionClarivate Analyticshttps://www.webofscience.com/Literature database used for data acquisition and search strategy.

References

  1. Sundar R, et al. Gastric cancer. Lancet. 2025;405(10494):2087–2102.
  2. Guan WL, He Y, Xu RH. Gastric cancer treatment: Recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57. doi:10.1186/s13045-023-01451-3.
  3. Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264–279.
  4. Yang P, et al. Trends and projections of the burden of gastric cancer in China and G20 countries: A comparative study based on the global burden of disease database 2021. Int J Surg. 2025;111(7):4854–4865.
  5. Liu Y, et al. Traditional Chinese medicine in the treatment of chronic atrophic gastritis, precancerous lesions and gastric cancer. J Ethnopharmacol. 2025;337(Pt 1):118812. doi:10.1016/j.jep.2024.118812.
  6. Xu W, et al. Traditional Chinese medicine for precancerous lesions of gastric cancer: A review. Biomed Pharmacother. 2022;146:112542. doi:10.1016/j.biopha.2021.112542.
  7. Liu Y, et al. Mechanisms of traditional Chinese medicine in the treatment and prevention of gastric cancer. Phytomedicine. 2024;135:156003. doi:10.1016/j.phymed.2024.156003.
  8. Lin J, et al. Molecular targets and mechanisms of traditional Chinese medicine combined with chemotherapy for gastric cancer: A meta-analysis and multi-omics approach. Ann Med. 2025;57(1):2494671. doi:10.1080/07853890.2025.2494671.
  9. Lu Y, et al. A comprehensive update: Gastrointestinal microflora, gastric cancer and gastric premalignant condition, and intervention by traditional Chinese medicine. J Zhejiang Univ Sci B. 2022;23(1):1–18.
  10. Wang L, et al. Traditional Chinese medicine for chronic atrophic gastritis: Efficacy, mechanisms and targets. World J Gastroenterol. 2025;31(9):102053. doi:10.3748/wjg.v31.i9.102053.
  11. Shao G, et al. Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug. J Ethnopharmacol. 2024;327:117999. doi:10.1016/j.jep.2024.117999.
  12. Ninkov A, Frank JR, Maggio LA. Bibliometrics: Methods for studying academic publishing. Perspect Med Educ. 2022;11(3):173–176.
  13. Wang YF, et al. Global trends and hotspots of artificial intelligence in pain management: A bibliometric analysis. Digit Health. 2026;12:20552076261460708. doi: [verify before submission].
  14. Chen G, Yan Z, Wang Y, Tao Q. Rheumatoid arthritis and fibromyalgia syndrome: A bibliometric and bioinformatics perspective on comorbidity research. J Multidiscip Healthc. 2025;18:6811–6827.
  15. Wang Y, et al. Research trends and hotspots in JAK inhibitors for ulcerative colitis: A bibliometric analysis from 2015 to 2024. J Multidiscip Healthc. 2025;18:6755–6771.
  16. Du Q, et al. Protocol for conducting bibliometric analysis in biomedicine and related research using CiteSpace and VOSviewer software. STAR Protoc. 2024;5(3):103269. doi:10.1016/j.xpro.2024.103269.
  17. Arruda H, et al. VOSviewer and Bibliometrix. J Med Libr Assoc. 2022;110(3):392–395.
  18. Xu J, et al. Global research hotspots and trends in constraint-induced movement therapy in rehabilitation over the past 30 years: A bibliometric and visualization study. Front Neurol. 2024;15:1375855. doi:10.3389/fneur.2024.1375855.
  19. Zhao Y, Chen GY, Fang M. Research trends of rheumatoid arthritis and depression from 2019 to 2023: A bibliometric analysis. J Multidiscip Healthc. 2024;17:4465–4474.
  20. Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: Epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023;20(5):338–349.
  21. López MJ, et al. Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol. 2023;181:103841. doi:10.1016/j.critrevonc.2022.103841.
  22. Dai Z, et al. Traditional Chinese medicine for gastric cancer: An evidence mapping. Phytother Res. 2024;38(6):2707–2723.
  23. Li Y, et al. Unraveling the mystery of efficacy in Chinese medicine formula: New approaches and technologies for research on pharmacodynamic substances. Arab J Chem. 2022;15(11):104302. doi:10.1016/j.arabjc.2022.104302.
  24. Wang H, et al. Anticancer efficacy of the ethyl acetate extract from the traditional Chinese medicine herb Celastrus orbiculatus against human gastric cancer. J Ethnopharmacol. 2017;205:147–157.
  25. Deng YQ, et al. Compound-composed Chinese medicine of Huachansu triggers apoptosis of gastric cancer cells through an increase in reactive oxygen species levels and suppression of proteasome activities. Phytomedicine. 2024;123:155169. doi:10.1016/j.phymed.2023.155169.
  26. Zhou J, et al. Decoding inflammatory mediators in the Correa’s cascade: From chronic gastritis to carcinogenesis and targeted therapies. Int Immunopharmacol. 2025;162:115191. doi:10.1016/j.intimp.2025.115191.
  27. Zhang A, et al. Qualitative and quantitative determination of chemical constituents in Jinbei oral liquid, a modern Chinese medicine for coronavirus disease 2019, by ultra-performance liquid chromatography coupled with mass spectrometry. Front Chem. 2023;11:1079288. doi:10.3389/fchem.2023.1079288. Retracted.
  28. Liu Z, et al. Targeting immunosenescence for improved tumor immunotherapy. MedComm (2020). 2024;5(11). doi:10.1002/mco2.777.
  29. Zhang Z, et al. Chinese medicines and natural medicine as immunotherapeutic agents for gastric cancer: Recent advances. Cancer Rep (Hoboken). 2024;7(9). doi:10.1002/cnr2.2134.
  30. Zeng Y, et al. Fisetin micelles precisely exhibit a radiosensitization effect by inhibiting PDGFRβ/STAT1/STAT3/Bcl-2 signaling pathway in tumor. Chin Chem Lett. 2025;36:109734. doi:10.1016/j.cclet.2024.109734.
  31. Guan X, et al. Blocking ubiquitin-specific protease 7 induces ferroptosis in gastric cancer via targeting stearoyl-CoA desaturase. Adv Sci (Weinh). 2024;11(18). doi:10.1002/advs.202307899.
  32. Wang Y, et al. Decorated CuO nanoparticles over chitosan-functionalized magnetic nanoparticles: Investigation of its anti-colon carcinoma and anti-gastric cancer effects. Arab J Chem. 2021;14:103201. doi:10.1016/j.arabjc.2021.103201.
  33. Huang W, et al. Yi-qi-hua-yu-jie-du decoction induces ferroptosis in cisplatin-resistant gastric cancer via the AKT/GSK3β/NRF2/GPX4 axis. Phytomedicine. 2024;123:155220. doi:10.1016/j.phymed.2023.155220.
  34. Chen GY, et al. Prediction of Rhizoma Drynariae targets in the treatment of osteoarthritis based on network pharmacology and experimental verification. Evid Based Complement Alternat Med. 2021;2021:5233462. doi:10.1155/2021/5233462.
  35. Sun S, et al. Potential mechanism of traditional Chinese medicine intervention in gastric cancer: Targeted regulation of autophagy. Front Pharmacol. 2025;16:1548672. doi:10.3389/fphar.2025.1548672.
  36. Wei Z, et al. Rhizopus nigricans polysaccharide activated macrophages and suppressed tumor growth in CT26 tumor-bearing mice. Carbohydr Polym. 2018;198:302–312.
  37. Yuan W, et al. The role of MAPK pathway in gastric cancer: Unveiling molecular crosstalk and therapeutic prospects. J Transl Med. 2024;22(1):1142. doi:10.1186/s12967-024-05998-8.
  38. Wang K, et al. Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells. Cancer Cell. 2024;42(9):1582–1597.e10.
  39. Liao GQ, et al. Mass spectrometry-based metabolomics as a powerful tool to unravel the components and mechanisms in traditional Chinese medicine. Chin Med. 2025;20(1):62. doi:10.1186/s13020-025-01112-2.
  40. Chen GY, et al. Mechanisms of total glucosides of paeony in alleviating methotrexate-induced liver injury. Drug Des Devel Ther. 2025;19:3407–3423.
  41. Jin Q, et al. Network and experimental pharmacology to decode the action of Wendan decoction against generalized anxiety disorder. Drug Des Devel Ther. 2022;16:3297–3314.
  42. Fan Y, et al. Dendrobin A inhibits gastric cancer: Mechanistic insights supported by integrated evidence. Phytomedicine. 2025;147:157215. doi:10.1016/j.phymed.2025.157215.
  43. Gemmell JS, Lucke-Wold B. Traditional Chinese medicine and modern technology: Network pharmacology and omics sequencing in gastric cancer. World J Gastrointest Oncol. 2025;17(3):102077. doi:10.4251/wjgo.v17.i3.102077.
  44. Ye HN, Liu XY, Qin BL. Research progress of integrated traditional Chinese and Western medicine in the treatment of advanced gastric cancer. World J Gastrointest Oncol. 2023;15(1):69–75.
  45. Li DH, Feng RQ. Modern technology-based exploration of mechanism of traditional Chinese medicine in prevention and treatment of gastric cancer. World J Gastrointest Oncol. 2024;16(9):3747–3751.
  46. Zhu X, et al. Efficacy and safety of TCM therapies combined with hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of gastric cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021;100(4). doi:10.1097/MD.0000000000024337.
  47. Wang FH, et al. The Chinese Society of Clinical Oncology clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun (Lond). 2024;44(1):127–172.
  48. Feng S, et al. Harnessing gene editing technology for tumor microenvironment modulation: An emerging anticancer strategy. Chem Eur J. 2024;30. doi:10.1002/chem.202402485.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Bibliometric AnalysisNetwork PharmacologyMolecular DockingEpithelial Mesenchymal TransitionChinese Herbal InjectionsAcupuncture TherapyMetabolomics